FC2-17590-80791
3 vaccinations
2 coded responses
26 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 233 / VA
- Registered
- 2021-03-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-20
Registered in v-safe
-
2021-03-20
Dose 1 — Pfizer-BioNTech
- 2021-03-20
-
2021-03-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-03-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-03-23
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-03-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-03-26
- 2021-03-29
- 2021-04-03
-
2021-04-10
Dose 2 — Pfizer-BioNTech
- 2021-04-10
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Fatigue or tirednessAdult check-in
- 2021-04-16
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-05-10
- 2021-05-22
- 2021-07-10
- 2021-10-11
- 2022-04-10
-
2022-04-13
Dose 3 — Pfizer-BioNTech
-
2022-04-27
Survey response — day 14, dose 3MedDRA: Malaise — Feeling: FairFree text: General malaiseMedDRA releases: 2024-11 · check-in free text available
- 2022-05-11
- 2022-05-25
-
2022-10-12
Survey response — 6 months, dose 3MedDRA: Bronchitis, Pneumonia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Bronchitis/pneumoniaMedDRA releases: 2024-11 · check-in free text available
-
2022-10-12
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-10-13
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-20 | Pfizer-BioNTech | |
| 2 | 2021-04-10 | Pfizer-BioNTech | |
| 3 | 2022-04-13 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 11 — day 14, dose 3
Symptoms: General malaise
Release 12 — 6 months, dose 3
Symptoms: Bronchitis/pneumonia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Pneumonia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release